Who can use Tibsovo(Ivosidenib)?

Who can use Tibsovo(Ivosidenib)?

Newly diagnosed acute myeloid leukemia (AML)

In combination with azacitidine, or as a single agent, for the treatment of adult patients with newly diagnosed AML who are 75 years of age and older, or who are ineligible for intensive induction chemotherapy due to comorbidities.

Relapsed or refractory AML

For the treatment of adult patients with relapsed or refractory AML.

Relapsed or refractory myelodysplastic syndromes (MDS)

For the treatment of adult patients with relapsed or refractory MDS.

Locally advanced or metastatic cholangiocarcinoma

For the treatment of adult patients with locally advanced or metastatic cholangiocarcinoma who have received prior therapy.